Sugentech, Inc. Logo

Sugentech, Inc.

Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.

253840 | KO

Overview

Corporate Details

ISIN(s):
KR7253840003
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 206 사무동2층 수젠텍, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sugentech, Inc. is an in-vitro diagnostic (IVD) company that develops and commercializes next-generation diagnostic products by integrating biotechnology (BT), nanotechnology (NT), and information technology (IT). The company specializes in immunochemical diagnostics, leveraging its proprietary platforms for high-level antibody development and high-sensitivity immunoassay technologies. Sugentech offers a range of diagnostic systems tailored to various healthcare settings: multi-immunoblot automation systems for hospitals and medical centers, point-of-care testing (POCT) for smaller clinics, and mobile health (m-Health) solutions for personal, at-home use. Its products are designed for the diagnosis of conditions such as infectious diseases, cardiovascular diseases, and diabetes, aiming to provide personalized and accessible digital healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 35.7 KB
2025-09-08 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.2 KB
2025-08-29 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 53.4 KB
2025-08-29 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 42.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 30.2 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.3 KB
2025-03-18 00:00
Annual / Quarterly Financial Statement
[첨부추가]사업보고서 (2024.12)
Korean 663.6 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 176.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 17.7 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 167.5 KB
2025-03-07 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 170.6 KB

Automate Your Workflow. Get a real-time feed of all Sugentech, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sugentech, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sugentech, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea
355690
aTYR PHARMA INC Logo
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.
United States of America
AUPH
AURORA CANNABIS INC Logo
A global producer and seller of medical and recreational cannabis and derivative products.
United States of America
ACB
Autolus Therapeutics plc Logo
Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
AUTL
AVADEL PHARMACEUTICALS PLC Logo
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
United States of America
AVDL
Avidity Biosciences, Inc. Logo
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
United States of America
RNA
Axsome Therapeutics, Inc. Logo
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.
United States of America
AYTU

Talk to a Data Expert

Have a question? We'll get back to you promptly.